Sero-epidemiologic study of hepatitis C virus infection in Fukuoka, Japan

• Published in: Journal of gastroenterology 1998-04, Vol.33 (2), p.218-222
• Main Authors: Sata, M, Nakano, H, Suzuki, H, Noguchi, S, Yamakawa, Y, Tanaka, E, Fukuizumi, K, Tanaka, K, Yoshida, H, Tanikawa, K
• Format: Article
• Language: English
• Subjects: Adult; Age Factors; Aged; Aged, 80 and over; Female; Hepacivirus - genetics; Hepatitis B Surface Antigens - blood; Hepatitis C - epidemiology; Hepatitis C Antibodies - blood; Humans; Japan - epidemiology; Liver Diseases - epidemiology; Liver Diseases - mortality; Male; Middle Aged; RNA, Viral - analysis; Seroepidemiologic Studies; Sex Factors
• ISSN: 0944-1174; 1435-5922
• DOI: 10.1007/s005350050073

We conducted an epidemiological study of 509 residents of H town, Fukuoka, Japan, to investigate the high mortality rate from liver disease. Antibodies to hepatitis C virus (HCV) (anti-HCV) were detected in 120 residents (23.6%); HCV RNA in 91 (17.9%), and hepatitis B surface antigen (HBsAg) in 13 (2.6%). Multivariate logistic regression analyses showed that presence of anti-HCV, male gender, and history of liver disease were associated with the presence of liver dysfunction, and that age of more than 40 years and a particular district were associated with the presence of anti-HCV. HCV RNA was more frequently detected in anti-HCV-positive men than women (41, or 85.4% versus 50, or 69.4%) (P < 0.05). The incidence of liver dysfunction was significantly higher in HCV RNA-positive men than women (32, or 66.7% versus 22, or 30.6%) (P < 0.05). These findings suggest that: (1) HCV was correlated with the high mortality rate from liver diseases, (2) there were district-related differences in the incidence of HCV, and (3) the lower frequency of elimination of HCV from men may explain why they showed a high mortality from liver disease.